Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a probiotic speed up pneumonia recovery in kids?

NCT ID NCT06348095

Disease control Sponsor: Wecare Probiotics Co., Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a probiotic called WecProB could help children with mycoplasma pneumonia get better faster. Sixty children aged 6 months to 12 years took either the probiotic or a placebo. The main goal was to see if the probiotic reduced the amount of pneumonia-causing bacteria in the body.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jun 2024

Finished

Aug 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 months to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. diagnosis of MPP based on typical clinical manifestations (e.g., fever, cough, abnormal pulmonary auscultation), radiographic evidence of pneumonia on chest imaging, and laboratory findings in accordance with current pediatric community-acquired pneumonia guidelines; 2. MP infection was confirmed in nasopharyngeal secretions and serum samples using PCR and ELISA; 3. age between 6 months and 12 years; 4. disease duration less than 2 weeks; 5. written informed consent provided by the guardians. Exclusion Criteria: 1. Previous history of wheezing; 2. Cardiovascular disease and congenital tracheal dysplasia; 3. pneumonia induced by other causes; 4. Dysplasia of bronchial and pulmonary tracts; 5. premature infants; 6. Combined with immunosuppressive diseases; 7. Presence of mental illness.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mycoplasma pneumoniae pneumonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Mycoplasma pneumoniae pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mycoplasma pneumoniae pneumonia

Contacts and locations

Locations

  • Zhihui Liu

    Chongqing, Chongqing Municipality, 405200, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.